نتایج جستجو برای: biologic

تعداد نتایج: 59316  

Journal: :Nature Biotechnology 2021

Journal: :The Columbia science and technology law review 2023

Can something be both open and secret? That is the conundrum facing society as trade secret rights chafe against patent in cutting-edge, biologic medicine. The conflict unsurprising. Trade has emerged a relatively late bloomer among family of intellectual property only recently begun to establish boundaries its own space, process which it will inevitably knock other doctrines already occupying ...

Journal: :Actas dermo-sifiliograficas 2015
J M Carrascosa N Rivera I Garcia-Doval G Carretero F Vanaclocha E Daudén F J Gómez-García P De-la-Cueva-Dobao E Herrera-Ceballos I Belinchón M Alsina J L Sánchez-Carazo M Ferrán J L Lopez-Estebaranz B Pérez-Zafrilla M Llamas R Rivera C Ferrándiz

BACKGROUND With the advent of biologic drugs in the management of moderate to severe psoriasis, there may have been a shift in therapeutic approach from rotational strategies to a unidirectional progression from topical treatments to the highest rung of the therapeutic ladder. We studied the frequency of switching from classic to biologic therapy and vice versa in a cohort of patients with psor...

2014
Jennifer C. Cather Jeffrey J. Crowley

Psoriasis is a chronic inflammatory skin disorder, which is associated with a significant negative impact on a patient's quality of life. Traditional therapies for psoriasis are often not able to meet desired treatment goals, and high-dose and/or long-term use is associated with toxicities that can result in end-organ damage. An improved understanding of the involvement of cytokines in the etio...

Journal: :Bulletin of the Hospital for Joint Disease 2013
Isabel Castrejón Kathryn A Gibson Theodore Pincus

Methotrexate (MTX) is well-established as the "anchor drug" for patients with rheumatoid arthritis (RA), to be used early and aggressively, with higher long-term effectiveness, tolerability, and safety than any other disease-modifying antirheumatic drug (DMARD). However, about 20% to 40% of patients experience incomplete responses to MTX and require further therapy, with options including other...

2013
Paul Emery Anthony Sebba Tom W J Huizinga

Clinical evidence demonstrates coadministration of tumour necrosis factor inhibitor (TNFi) agents and methotrexate (MTX) is more efficacious than administration of TNFi agents alone in patients with rheumatoid arthritis, leading to the perception that coadministration of MTX with all biologic agents or oral disease-modifying antirheumatic drugs is necessary for maximum efficacy. Real-life regis...

Journal: :Archivos de Bronconeumología 2021

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید